A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)

Relapse Rate of Uveitis Post-Methotrexate Treatment in Juvenile Idiopathic Arthritis

(2010) Viera Kalinina Ayuso et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

(2010) J. L. Nam et al.   ANNALS OF THE RHEUMATIC DISEASES

Chronic Anterior Uveitis in Children: Clinical Characteristics and Complications

(2009) Gary N. Holland et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

New advances in the management of juvenile idiopathic arthritis--1: Non-biological therapy

(2009) M W Beresford et al.   Archives of Disease in Childhood-Education and Practice Edition

Epidemiology and Course of Disease in Childhood Uveitis

(2009) Janine A. Smith et al.   OPHTHALMOLOGY

Non-Infectious Pediatric Uveitis

(2009) Srilakshmi M. Sharma et al.   PEDIATRIC DRUGS

Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis

(2008) Silvia Magni-Manzoni et al.   ARTHRITIS AND RHEUMATISM

Infliximab for Inflammatory Bowel Disease in Denmark 1999–2005: Clinical Outcome and Follow-Up Evaluation of Malignancy and Mortality

(2008) Sarah Caspersen et al.   Clinical Gastroenterology and Hepatology

Update on biologics in juvenile idiopathic arthritis

(2008) Norman T Ilowite   CURRENT OPINION IN RHEUMATOLOGY

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE